Medication-info.com Search Menu

Rocuronium: Uses, Side Effects and Dosage

Status:
Prescription (Rx) Current since November 19, 2026 Facts
Strength:
10 mg/mL
Active ingredient:

Patient information: uses, side effects, how to take - Rocuronium

INSTRUCTIONS FOR USE

NOTES:

  • Do not introduce any other fluid into the syringe at any time.
  • Do not dilute for intravenous push.
  • Do not re-sterilize the syringe.
  • Do not use this product on a sterile field.
  • This product is for single dose only.
  1. 1. Visually inspect the syringe. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if the prefilled syringe has been damaged.
  2. 2.

    Twist the tamper evident (TE) cap to remove. The syringe tip cap should remain attached. (Figure 2)

  3. 3. Push plunger rod slightly to break the stopper loose while syringe tip cap is still on.
  4. 4.

    Remove and discard the syringe tip cap (Figure 3).

  5. 5. Expel air bubble(s). Adjust the dose (if applicable).
  6. 6. Administer the dose. Discard the used syringe into an appropriate receptacle.

For more information concerning this drug, please call Fresenius Kabi USA, LLC at 1-800-551-7176.

To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Kabi USA, LLC at 1-800- 551-7176 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

US Patents 10661030, 11964142, and 12171992 (prefilled syringe)

Manufactured by:

www.fresenius-kabi.com/us

451874B

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 217472 · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Rocuronium

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Nondepolarizing Neuromuscular Blocker
Active ingredient Rocuronium bromide 10 mg/mL
Dosage form Injection, solution
Route Intravenous
Marketing status listed in the FDA NDC Directory
Company (applicant) FRESENIUS KABI USA
FDA approval NDA 217472New Drug Application (NDA) Approved June 9, 2025
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 22 labelers list this drug on DailyMed
Drug shortage
  • Current since November 19, 2026
Packages (NDC)
Package
10 mg/mL – 5 ml in 1 syringe / 10 in 1 carton NDC 76045-220-05
10 mg/mL – 5 ml in 1 syringe / 10 in 1 carton NDC 76045-221-05

Source: FDA drug labeling via NLM DailyMed, data as of November 21, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.